Abstract
The need to integrate complementary medicine (CM) consultation in supportive care of patients with cancer is acknowledged by oncologists owing to the ongoing research on CM efficacy and awareness of its potential risks. In this article, we aim to provide oncologists with models for CM integration within supportive care. Descriptive analysis of key elements which facilitate CM integration is presented by physicians leading six integrative cancer care programs across four continents. Perspectives of integration are supplemented by a literature review, quantitative data on the clinical activity in each center, and qualitative narrative-based citations of seven oncology patients and healthcare providers. It is recommended that CM consultation be provided by physicians with extensive CM training. The following key elements were identified as essential for integrative program design within oncological supportive care: (1) Location of the integrative physician (IP) room within the oncology department area, (2) Required oncologist referral to CM consultation, (3) Allocated time to IP-oncologist communication, (4) Research-based integrative practice, (5) Inclusion of paid professional CM practitioners, (6) Institutional cost covered service. Integration of CM consultation within oncological supportive care needs to take in account six key elements that ensure high-quality evidence-based concomitant integrative practice.
Similar content being viewed by others
References
Burstein HJ. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000;18:2501–4.
White F. Annual report on complementary and alternative medicine–Fiscal year 2009. Office of cancer complementary and alternative medicine, National Cancer Institute, 2009.
Geffen JR. Integrative oncology for the whole person: a multidimensional approach to cancer care. Integr Cancer Ther. 2010;9(1):105–21.
Frenkel M, Cohen L, Peterson N, et al. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther. 2010;9(3):276–83.
Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan-Kettering Experience. Curr Oncol. 2008;Suppl 2(s108):es68–71.
Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.
Ben-Arye E, Schiff E, Steiner M, Silbermann M. Wheatgrass in Afifi’s garden: sprouting integrative oncology collaborations in the Middle East. J Clin Oncol. 2011;29(7):944–6.
Koithan M, Bell IR, Caspi O, et al. Patients’ experiences and perceptions of a consultative model integrative medicine clinic: a qualitative study. Integr Cancer Ther. 2007;6(2):174–84.
Harrington JE, Baker BS, Hoffman CJ. Effect of an integrated support programme on the concerns and wellbeing of women with breast cancer: a national service evaluation. Complement Ther Clin Pract. 2012;18(1):10–5.
Kligler B, Homel P, Harrison LB, et al. Impact of the Urban Zen initiative on patients’ experience of admission to an inpatient oncology floor: a mixed-methods analysis. J Altern Complement Med. 2011;17(8):729–34.
Ben-Arye E, Schiff E, Steiner M, et al. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care. Int J Gynecol Cancer. 2011;22(1):146–53.
Kligler B, Homel P, Harrison LB, et al. Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care. 2011;17(12):779–84.
Ben-Arye E, Schiff E, Golan O. Ethical issues in integrative oncology. Hematol Oncol Clin North Am. 2008;22(4):737–53.
Coulter ID, Ellison MA. Hilton L, et al. Hospital-based integrative medicine. Hospital-based integrative medicine: a case study of the barriers and factors facilitating the creation of a center. Santa Monica, CA: RAND Corporation, 2007. http://www.rand.org/pubs/monographs/MG591.
Ben-Arye E, Schiff E, Shapira C, et al. Modeling an integrative oncology program within a community-centered oncology service in Israel. Patient Educ Couns. 2012;. doi:10.1016/j.pec.2012.02.011.
Smithson J, Britten N, Paterson C, et al. The experience of using complementary therapies after a diagnosis of cancer: a qualitative synthesis. Health (London). 2012;16(1):19–39.
Frenkel M, Cohen L. Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol Oncol Clin North Am. 2008;22(4):727–36.
Caspi O, Bell IR, Rychener D, et al. The tower of babel: communication and medicine: an essay on medical education and complementary-alternative medicine. Arch Intern Med. 2000;160(21):3193–5.
Schiff E, Frenkel M, Shilo M, et al. Bridging the physician and CAM practitioner communication gap: suggested framework for communication between physicians and CAM practitioners based on a cross professional survey from Israel. Patient Educ Couns. 2011;85(2):188–93.
Schiff E, Ben-Arye E, Attias S, et al. Perceiving integration of a complementary medicine service within a general surgery department through documentation of consultations: a thematic analysis. Patient Educ Couns 2012; 2012 Mar 16. [Epub ahead of print].
Bar-Sela G, Goldberg H, Beck D, et al. Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a viscum album extract. Anticancer Res. 2006;26(1B):709–13.
Xu H, Chen K. Integrative medicine: the experience from China. J Altern Complement Med. 2008;14(1):3–7.
Sharf BF, Geist Martin P, Cosgriff-Hernández KK, et al. Trailblazing healthcare: institutionalizing and integrating complementary medicine. Patient Educ Couns 2012; 2012 Apr 1. [Epub ahead of print].
Lawenda BD, Friedenthal SA, Sagar SM, et al. Systems modeling in integrative oncology. Integr Cancer Ther. 2011;11(1):5–17.
Beatty L, Koczwara B, Knott V, et al. Why people choose to not use complementary therapies during cancer treatment: a focus group study. Eur J Cancer Care (Engl). 2012;21(1):98–106.
Ben-Arye E, Steiner M, Karkabi K, et al. Barriers to integration of traditional and complementary medicine in supportive cancer care of Arab patients in northern Israel. Evid Based Complement Alternat Med. 2012;401867:2012.
Bar-Sela G, Wollner M, Hammer L, et al. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer. 2012.
Büssing A, Hedtstück A, Khalsa SB, et al. Development of specific aspects of spirituality during a 6-month intensive yoga practice. Evid Based Complement Alternat Med. 2012;2012:981523.
Acknowledgments
The article is a follow-up to the UK-Israeli CAM-Integrative Medicine workshop that was held at Bnai-Zion Medical Center in Haifa, Israel, with the support of the Israeli Society for Complementary Medicine, the UK College of Medicine, Bnai Zion Medical Center, the Technion-Israel Institute of Technology, Lin Medical Center of Clalit health services, and the Academic Study Group for Israel and the Middle East.
Conflict of interest
The authors have declared no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ben-Arye, E., Schiff, E., Zollman, C. et al. Integrating complementary medicine in supportive cancer care models across four continents. Med Oncol 30, 511 (2013). https://doi.org/10.1007/s12032-013-0511-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-013-0511-1